We are live on ! Find out more
AUTL

Autolus Therapeutics
AUTL

43 hedge funds and large institutions have $167M invested in Autolus Therapeutics in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 12

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

7% less funds holding

Funds holding: 46 → 43 (-3)

17.65% less ownership

Funds ownership: 47.54% → 29.89% (-18%)

33% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 9

51% less capital invested

Capital invested by funds: $344M → $167M (-$177M)

Holders
43
Holders Change
-3
Holders Change %
-6.52%
% of All Funds
0.94%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
16
Reduced
12
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
JAM
Jupiter Asset Management
United Kingdom
+$9.32M
2
Millennium Management
Millennium Management
New York
+$8.3M
3
TAM
TFG Asset Management
Cayman Islands
+$3.97M
4
Victory Capital Management
Victory Capital Management
Texas
+$2.62M
5
Capital International Investors
Capital International Investors
California
+$2.46M

Top Sellers

1
WIM
Woodford Investment Management
United Kingdom
-$126M
2
CAM
Cormorant Asset Management
Massachusetts
-$2.91M
3
SFM
Sphera Funds Management
Israel
-$2.86M
4
SGCM
Sand Grove Capital Management
United Kingdom
-$1.63M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
Walleye Trading
51
Walleye Trading
New York
– -$170K -10,556 Closed
Walleye Capital
52
Walleye Capital
New York
– -$168K -10,431 Closed
1 2
3